XML 57 R42.htm IDEA: XBRL DOCUMENT

SHARE-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2016


				Weighted Average	Aggregate Intrinsic
		Weighted Average		Remaining	Value
	Options	Exercise Price		Contractual Term	(in thousands)
Outstanding as of December 31, 2015	144,197	$	17.98
Granted	—		—
Exercised	(5,647)		3.39
Forfeited	—		—
Expired	(71,112)		12.52
Outstanding as of December 31, 2016	67,438	$	24.96	4.38	$	24,220
Exercisable as of December 31, 2016	67,438	$	24.96	4.38	$	24,220

Summary of information with respect to all outstanding and exercisable stock options


			Options Outstanding					Options Exercisable
						Weighted Average
			Number of options	Weighted Average		Remaining		Number	Weighted Average
Exercise Price or Range			outstanding	Exercise Price		Contractual Term		Exercisable	Exercise Price
$3.39	-	$13.50	52,115	$	6.29	5.01	years	52,115	$	6.29
$54.40	-	$92.50	5,823		57.67	3.07	years	5,823		57.67
$99.90	-	$128.50	9,500		107.34	1.75	years	9,500		107.34
			67,438	$	24.96	4.38	years	67,438	$	24.96

Schedule of RSU activity


		Weighted Average
		Grant-Date Fair Value
	Number of Shares	Per Share
Unvested as of December 31, 2015	377,810	$	4.87
Granted	411,910	$	2.84
Vested	(198,762)	$	4.73
Forfeited	(98,782)	$	3.22
Unvested as of December 31, 2016	492,176	$	3.56

Schedule of share-based compensation expense, net of taxes withheld


	For the Years Ended
	December 31,
	2016		2015
Share-based compensation expense:
Cost of sales	$	90	$	131
Selling, general and administrative		663		788
Income tax benefit (1)		—		—
Net effect of share-based compensation expense on net income (loss)	$	753	$	919
Reduction in earnings per share:
Basic earnings per share	$	0.05	$	0.06

Diluted earnings per share	$	0.05	$	0.06

(1)

Income tax benefit is not illustrated because the Company is currently in a full tax valuation allowance position and an actual income tax benefit was not realized for the years ended December 31, 2016 and 2015. The result of the income (loss) situation creates a timing difference, resulting in a deferred tax asset, which is fully reserved for in the Company’s valuation allowance.

(2)

Diluted earnings per share for the year ended December 31, 2015 does not include common stock equivalents due to their anti‑dilutive nature as a result of the Company’s net losses for the period. Accordingly, basic earnings per share and diluted earnings per share are identical for the period.